S&P/ASX 200 Index (ASX: XJO) mining and materials shares outperformed last week, rising 2.5% vs. an 0.4% bump for the index.

As earnings season comes to a close today, let's review new ratings on three popular ASX 200 mining shares.

BHP Group Ltd (ASX: BHP)

BHP is a major iron ore producer and also the world's largest copper producer.

Last week, the BHP share price hit a new record of $68.77 per share.

Morgans has a buy rating on the market's largest ASX 200 mining share. 

On The Bull this week, analyst Damien Nguyen said: 

BHP offers exposure to a portfolio of high quality mining assets and remains well positioned to benefit from long term demand for copper and other critical minerals.

A strong operating performance, healthy cash generation and a disciplined approach to capital allocation continue to support the investment case.

While iron ore remains important, increasing copper exposure provides leverage to electrification and decarbonisation trends.

BHP appeals for potential capital growth, income and for diversified resources exposure.

The company posted an attributable profit of $US9.8 billion in full year 2026, up 9 per cent on the prior corresponding period.

Revenue of $US58.8 billion was up 15 per cent.

BHP is among 37 ASX shares going ex-dividend this week.

The miner declared a final fully franked dividend of 99 US cents per share for FY26.

BHP shares will trade ex-dividend on Thursday.

Rio Tinto Ltd (ASX: RIO)

Rio Tinto is a diversified miner with significant iron ore, copper, and lithium operations.

Morgans has a hold rating on this ASX 200 mining share.

Nguyen explained:

Rio Tinto continues to generate strong cash flow from its world class iron ore operations, while building exposure to copper and lithium.

The company maintains a robust balance sheet and offers attractive shareholder returns, supported by low cost assets.

However, iron ore remains the primary earnings driver, leaving profits exposed to movements in commodity prices and Chinese demand.

Given this balance of quality and cyclical risk, we see Rio Tinto as fairly valued at recent levels.

PLS Group Ltd (ASX: PLS)

PLS Group is the ASX 200's most valuable lithium share by market capitalisation.

Morgans has a sell recommendation on PLS Group shares.

Analyst Annabelle Sleeman commented:

PLS delivered an in-line FY26 Underlying EBITDA result and surprised with a maiden 5cps fully franked final dividend (22% FCF payout).

We view PLS as fairly valued at current levels, with its premium to peers already reflecting the company's best-in-class execution, balance sheet and growth optionality.

Depleted lithium inventories leave scope for short-term upside, though we see the medium-term outlook as more volatile given uncertainty around supply and demand drivers.

PLS Group shares will trade ex-dividend on Wednesday.

The post Buy, hold, sell: Rio Tinto, PLS Group, BHP shares appeared first on The Motley Fool Australia.

More reading

• Up 56%! 3 reasons to still buy BHP shares today
• Is it a great time to buy Rio Tinto shares?
• These are the 10 most shorted ASX shares
• Experts name 2 ASX 200 blue chip shares to buy this week
• By September 2027, BHP shares could turn $10,000 into…

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended BHP Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares rose 0.37% last week and are up 4.2% in the calendar year to date (YTD).

Today is the final day of earnings season.

We will hear from Michael Hill International Ltd (ASX: MHJ) and Monash IVF Group Ltd (ASX: MVF) today.

Meanwhile, if you're keeping an eye on dividend opportunities, there are 37 ASX shares going ex-dividend this week.

Let's start the day with some new ratings from the experts (courtesy The Bull). 

CSL Ltd (ASX: CSL)

CSL shares rose 2.39% to $172.32 apiece last week, and are up 0.2% in the YTD.

Damien Nguyen from Morgans has a buy rating on this ASX 200 healthcare share. 

Nguyen said: 

CSL is a global healthcare leader with strong competitive advantages across plasma therapies, vaccines and specialty medicines.

Demand for its products remain largely independent of economic conditions.

In our view, the latest full year result in 2026 is generating confidence that repeated earnings downgrades are behind CSL.

With defensive earnings, global market leadership and attractive long term growth prospects, we view CSL as an appealing investment opportunity.

Goodman Group (ASX: GMG)

The Goodman Group share price rose 2.38% to $27.92 last week, and is down 9% for the YTD.

Jonathan Tacadena from MPC Markets has a hold rating on this ASX 200 property share. 

Tacadena said: 

Goodman Group is a global industrial property and data centre developer. It delivered an operating profit of $2.675 billion in full year 2026, up 15.7 per cent on the prior corresponding period.

Data centres drove work in progress to $19.7 billion across 50 projects in 12 countries.

Property investment income of $722.1 million was up 7 per cent. Occupancy remained high at 95.6 per cent.

The company is targeting earnings per share growth of 9 per cent in full year 2027.

Earnings momentum and management quality justify holding the position.

Commonwealth Bank of Australia (ASX: CBA)

The CBA share price fell 0.47% to $157.25 last week, and is down 2% for the YTD.

Nguyen has a sell rating on this ASX 200 bank share, and said:

The CBA continues to deliver resilient earnings, strong capital levels and industry leading returns, reinforcing its position as Australia's premier banking franchise.

However, the earnings growth outlook remains relatively modest as intense competition and margin pressure possibly weigh on profitability.

Despite these headwinds, the stock trades at a significant premium to its peers and historical valuations.

With limited scope for earnings upgrades, we believe the share price leaves little room for disappointment.

The post Buy, hold, sell: Commonwealth Bank, Goodman Group, CSL shares appeared first on The Motley Fool Australia.

More reading

• Experts name 2 ASX 200 blue chip shares to buy this week
• Are these 2 top Vanguard ETFs still worth buying today?
• The 2 top yielding ASX 200 bank stocks revealed (Hint: Not CBA shares)
• Are ASX bank shares a buy in September?
• How to build an ASX portfolio you do not need to check every day

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Goodman Group. The Motley Fool Australia has recommended CSL and Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

ASX 200 materials and mining shares outperformed the other 10 market sectors last week.

Materials and mining stocks rose by a modest 2.5% over the week, according to CommSec data.

Meanwhile, the benchmark S&P/ASX 200 Index (ASX: XJO) closed out the week up 0.37% to 9,092.3 points on Friday.

Only four sectors finished in the green last week.

Let's review.

ASX materials and mining shares led the market

As earnings season continued last week, several ASX mining shares reached new record highs.

Among them was BHP Group Ltd (ASX: BHP), which reset its historical high at $68.77 per share on Wednesday.

BHP is not only the largest miner on the market, it's also the most valuable company of the entire ASX 200.

The BHP share price finished the week 3.28% higher at $67.30 per share.

The Fortescue Ltd (ASX: FMG) share price increased 1.8% to $18.07.

Rio Tinto Ltd (ASX: RIO) shares lifted 1.52% to $178.04.

Diversified ASX 200 miner, Mineral Resources Ltd (ASX: MIN), fell 1.25% to $65.46 per share.

The South32 Ltd (ASX: S32) share price leapt 7.36% to $5.25 on Friday.

Pure-play ASX copper share Sandfire Resources Ltd (ASX: SFR) surged 7.81% to $23.34 per share.

ASX gold share Northern Star Resources Ltd (ASX: NST) ascended 3.38% to $24.78.

Newmont Corporation CDI (ASX: NEM) shares rose 1.64% to $182.80.

The Evolution Mining Ltd (ASX: EVN) share price closed at $15.67, up 2.08%.

ASX 200 lithium stock PLS Group Ltd (ASX: PLS) jumped 5.72% to $5.36 per share.

The IGO Ltd (ASX: IGO) share price rose 2.63% to $8.58.

Lynas Rare Earths Ltd (ASX: LYC) shares edged 0.31% higher to $16.26.

Among the non-mining ASX 200 materials shares, BlueScope Steel Ltd (ASX: BSL) rose 1.48% to $30.86.

The James Hardie Industries plc (ASX: JHX) share price fell 3.31% to $41.42.

Orica Ltd (ASX: ORI) shares decreased 0.81% to $21.98.

Several mining shares are among 37 companies going ex-dividend next week.

ASX 200 market sector snapshot

Here's how the 11 market sectors stacked up last week, according to CommSec data.

Over the five trading days:

The post ASX 200 mining shares outperform in final week of earnings season appeared first on The Motley Fool Australia.

More reading

• Up 56%! 3 reasons to still buy BHP shares today
• Is it a great time to buy Rio Tinto shares?
• Why Liontown, Northern Star and Telstra shares are turning heads on Monday
• Why this ASX gold-copper stock could rocket 90%
• These are the 10 most shorted ASX shares

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Lynas Rare Earths Ltd. The Motley Fool Australia has recommended BHP Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX All Ords Index (ASX: XAO) shares are 0.5% higher at 9,290.9 points on Friday.

As earnings season nears its end, brokers have updated their ratings as 12-month price targets on many ASX All Ords shares.

The following four shares have major upside potential over the next 12 months, according to the experts.

Temple & Webster Group Ltd (ASX: TPW)

The Temple & Webster share price is $4.75, up 2.8% today and down 80% over 12 months. 

Canaccord Genuity reiterated its buy call on this ASX retail share following the online furniture seller's FY26 results.

The broker has a 12-month target price of $9, which implies a potential 89% upside from here.

betr Entertainment Ltd (ASX: BBT)

The betr Entertainment share price is 20 cents, up 1% today and down 34% over 12 months.

Morgans maintained its buy rating on this ASX consumer discretionary share after the company's FY26 results.

The broker kept its target price at 36 cents, implying a potential 82% upside from here.

Morgans said:

BETR Entertainment (BBT) finished the year strongly, with normalised EBITDA of $6.1m in the second half against guidance of $5m to $8m, a $19.3m swing on the first half.

Full year normalised EBITDA of -$7.1m was a touch below our -$6.2m, with a gross profit beat offset by a higher cost of doing business.

Encouragingly, current trading remains healthy. Through the first eight weeks of FY27, turnover is up more than 20%, new customers have almost doubled, CPA is down 31% and promotional cost is down 9%, all excluding the FIFA World Cup.

The company announced the launch of its new first to market 'Wildcards' same game multi (SGM) feature that will launch during the Wildcard AFL round this weekend.

Judo Capital Holdings Ltd (ASX: JDO)

The Judo Capital share price is $1.01, down 0.8% today and down 42% over 12 months. 

Morgans reiterated its buy recommendation on this ASX bank share after reviewing Judo's FY26 results.

The broker said: 

FY26 PBT landed towards the top end of the revised guidance range and FY27 guidance was reaffirmed offering strong earnings growth.

EPS forecasts moderated 2-6%.

The broker trimmed its 12-month price target from $1.47 to $1.42, suggesting a potential 40% upside ahead.

DigiCo Infrastructure REIT (ASX: DGT)

The DigiCo Infrastructure REIT share price is $2.62, up 1.2% today and down 12% over 12 months. 

Morgans kept its buy rating in place on this ASX real estate investment trust (REIT) after DigiCo's FY26 results.

The broker has a 12-month price target of $3.60, implying a 37% upside ahead.

The broker said: 

The signed Letters of Intent (LOIs) over the remaining 52MW would take the Australian portfolio to full capacity — a strong demand signal that de-risks management's pathway to $250m of EBITDA.

However the ramp-up in earnings is back-ended, hence FY27 guidance was ~8% below MorgansF and ~13% below Consensus.

Liquidity of ~$1.2bn funds the ~$1.2bn capex bill, with management calling out no need for additional equity.

We still see clear value, but the cashflows are pushed out — this is now an FY28-into-FY29 story.

The post 4 ASX All Ords shares with 40% to 90% upside post-results: experts appeared first on The Motley Fool Australia.

More reading

• Buy, hold, sell: Breville, Car Group, Temple & Webster shares
• Here are the top 10 ASX 200 shares today
• Buy, hold, sell: Judo Capital, Healius, BHP shares
• Buy, hold, sell: DigiCo Infrastructure REIT, CBA, Telstra shares
• 2 ASX shares that could rise up to 45% following earnings results 

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Temple & Webster Group. The Motley Fool Australia has recommended Temple & Webster Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares are 0.4% higher at 9,070.7 points on the second last day of earnings season.

Brokers have been busily reviewing earnings results and updating their ratings and 12-month price targets accordingly.

Here is a sample of ASX shares that have scored upgraded ratings, and why.

Sigma Healthcare Ltd (ASX: SIG)

The Sigma Healthcare share price is $2.68, up 2.2% today and down 13% over 12 months.

Sigma Healthcare released its FY26 results this week.

Morgans upgraded the ASX 200 healthcare share from accumulate to buy today.

The broker shaved its 12-month price target from $3.30 to $3.19.

This implies a potential 12% upside ahead.

Morgans said:

SIG has posted its FY26 result which was in line with our and consensus forecasts. Highlights included EBIT growth of >20%, Australia CW LFL sales were 13.4% (1H 15.0%; 2H: 11.8%), International CW LFL sales of 12.2%.

We note the slight moderation in 2H in Australia was driven by a later start to the cold and flu season and cycling a very strong pcp.

SIG is targeting double-digit revenue and earnings growth for FY27.

The market has marked the shares down 7% post the FY26 results and possible sell down by some of the founders (up to 4.7% of issued capital).

We believe the share price fall is overdone and provides us with an opportunity to move our recommendation to BUY (from ACCUMULATE).

Adairs Ltd (ASX: ADH)

The Adairs share price is $1.41, down 2.1% today and down 49% over 12 months.

Adairs released its FY26 report this week.

Morgans upgraded the ASX consumer discretionary share to a buy rating.

The broker has a 12-month price target of $1.80, suggesting 27% upside from here.

Morgans said:

ADH reported FY26 underlying EBIT of $55.0m which was down 0.4% on the pcp and within guidance range of $53.5-55.5m.

Adairs and Mocka delivered strong EBIT growth (+14.9%/ +32.1%).

Focus on Furniture remains a drag with EBIT down 67.6% to $3.8m (~$2.0m loss in 2H) with management now guiding a two-year turnaround.

Given the underperformance, ADH recognised a non-cash impairment charge of $63.5m ($56.7m post tax).

We see the core Adairs banner set to deliver strong growth in FY27 driven by GM improvement and cost control, along with solid growth in Mocka offsetting weakness in Focus.

Given the share price weakness, we have upgraded to a BUY recommendation (from ACCUMULATE).

Polynovo Ltd (ASX: PNV)

The Polynovo share price is $1.04, up 1% today and down 24% over 12 months.

Polynovo released its FY26 earnings this week.

Bell Potter upgraded Polynovo shares to a buy rating today.

The broker increased its 12-month price target from $1 to $1.22.

This suggests a potential 18% upside ahead.

Bell Potter said:

The key concerns underpinning our July downgrade have eased sufficiently to restore confidence in the earnings outlook.

US trading improved into year-end and July, gross margin pressures appear largely temporary, and better-than-expected cost control
provides greater operating leverage as revenue scales.

We also see incremental upside from SynPath, with management now outlining a clearer strategy for entry into the US outpatient market, which is not yet reflected in our forecasts.

Netwealth Group Ltd (ASX: NWL)

The Netwealth share price is $21.60, up 0.4% today and down 38% over 12 months.

Netwealth released its FY26 earnings this week.

Morgans raised the ASX 200 financial share to a buy call with a $27.50 target.

This implies potential gains of 28% ahead for Netwealth shares.

Morgans said:

NWL reported FY26 Revenue +21%; EBITDA +18%; and NPAT +16% on pcp, which was largely in line with MorgF / Consensus expectations.

Whilst flows momentum 1Q27 to date has seen a slower start, NWL reaffirmed its FY27 Flows guidance of $18-20bn, with the cadence of flows from MS and other sources expected to step up over the course of the year.

The post 4 ASX shares scoring upgrades in the final week of earnings season appeared first on The Motley Fool Australia.

More reading

• Top brokers name 3 ASX shares to buy next week
• Buy, hold, sell: Netwealth, Sigma Healthcare, and Wesfarmers shares
• 3 ASX 200 shares to buy post-results: broker
• Why now is the time to buy low on these ASX healthcare shares with up to 84% upside
• 5 things to watch on the ASX 200 on Friday

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Adairs, Netwealth Group, and PolyNovo. The Motley Fool Australia has positions in and has recommended Adairs and Netwealth Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares are 0.4% higher at 9,077.7 points on Friday.

As earnings season nears its end, Morgans has reviewed the following companies' reports and given them a buy rating.

Here's why.

WiseTech Global Ltd (ASX: WTC)

The WiseTech share price is $41.14, up 4% today and down 59% over 12 months.

WiseTech released its FY26 results this week.

Morgans reiterated its buy rating on the ASX 200 tech share.

The broker cut its 12-month price target from $67 to $62.50.

This implies a potential 52% upside ahead for WiseTech shares.

Morgans said:

WTC's FY26 result was largely in line with Morgans forecasts (MorgansF), with FY26 revenue of US$1,396m and EBITDA of US$558m coming in towards the lower end of its initial FY26 guidance range.

While CargoWise revenue growth of +11% was softer than expected, WTC delivered annualised run-rate savings of ~US$115m in FY26, supporting further margin expansion into FY27.

FY27 guidance will see revenue growth 2H-weighted, reflecting the timing of growth initiatives, while Underlying EBITDA guidance of US$725-780m implies EBITDA margins tracking back towards 49-51%.

Flight Centre Travel Group Ltd (ASX: FLT)

The Flight Centre share price is $12.07, down 1% today and down 5% over 12 months.

Flight Centre released its FY26 report this week.

Morgans reiterated its buy rating on the ASX 200 consumer discretionary share.

The broker lowered its 12-month price target from $14.80 to $14.25.

This implies potential capital gains of 18% ahead for Flight Centre shares.

Morgans said:

FLT's FY26 result came in at the lower end of guidance which is disappointing given its 18 June trading update. Leisure was the key miss for us. Corporate had a strong year (+28% NPBT growth), while Leisure was weak (NPBT -22%) given the Middle East conflict.

Outlook comments disappointed with Corporate expected to have a weak 1H27, followed by growth in the 2H27. Pleasingly, Leisure is off to a strong start.

While investors will need to be patient for another six months, FLT's fundamentals remain attractive (FY27F PE of 11.6x) …

When operating conditions ultimately improve, both its earnings and share price will be materially higher.

Netwealth Group Ltd (ASX: NWL)

The Netwealth share price is $21.40, down 0.5% today and down 38% over 12 months.

Netwealth released its FY26 earnings this week.

Morgans increased the ASX 200 financial share to a buy rating with a $27.50 target.

This implies potential gains of 28% ahead for Netwealth shares.

Morgans said:

NWL reported FY26 Revenue +21%; EBITDA +18%; and NPAT +16% on pcp, which was largely in line with MorgF / Consensus expectations.

Whilst flows momentum 1Q27 to date has seen a slower start, NWL reaffirmed its FY27 Flows guidance of $18-20bn, with the cadence of flows from MS and other sources expected to step up over the course of the year.

The post 3 ASX 200 shares to buy post-results: broker appeared first on The Motley Fool Australia.

More reading

• Why I think Xero and WiseTech shares are strong buys
• These are the 10 most shorted ASX shares
• 4 ASX shares I'd buy with $5,000 in September
• 3 ASX growth shares to buy in September
• Warren Buffett's playbook: 3 cheap ASX shares that could soar up to 60%

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Netwealth Group and WiseTech Global. The Motley Fool Australia has positions in and has recommended Netwealth Group and WiseTech Global. The Motley Fool Australia has recommended Flight Centre Travel Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares are 0.3% higher at 9,061.6 points on the second last day of earnings season.

This week, brokers indicated continued confidence in several ASX 200 shares.

Let's check them out.

Coles Group Ltd (ASX: COL)

The Coles share price is $23.40, down 1.4% today and down 3% over 12 months. 

Over the past month, this ASX 200 consumer staples share has fallen 2%.

Morgan Stanley renewed its buy rating on Coles shares this week.

The broker has a 12-month price target of $25.

This suggests a potential 6% upside ahead.

Mineral Resources Ltd (ASX: MIN)

The Mineral Resources share price is $64.35, down 1.6% today and up 74% over 12 months. 

Over the past month, this ASX 200 mining share has soared 21%.

Bell Potter renewed its buy rating on Mineral Resources shares today.

The broker has a $75 target, which implies a 15% upside ahead.

Woolworths Group Ltd (ASX: WOW)

The Woolworths share price is $39.04, down 1.3% today and up 38% over 12 months.

This ASX 200 supermarket share has fallen 2% over the past month.

Morgans reiterated its buy rating on Woolworths shares with a price target of $43.50.

This implies potential capital gains of 11% ahead.

Centuria Capital Group (ASX: CNI)

The Centuria Capital share price is $1.18, down 1.3% today and down 52% over 12 months. 

Over the past month, this ASX real estate investment trust (REIT) has slumped 22%.

UBS maintained its buy rating on Centuria Capital shares today.

The broker lowered its target from $2.11 to $1.80, suggesting a 52% upside ahead.

Paladin Energy Ltd (ASX: PDN)

The Paladin Energy share price is $11.77, down 2.6% today and up 62% over 12 months.

Over the past month, this ASX 200 uranium share has ripped 28% higher.

Jefferies reaffirmed its buy rating on Paladin Energy shares yesterday.

The broker raised its price target from $12.50 to $14.50.

This suggests a potential 22% upside ahead.

NextDC Ltd (ASX: NXT)

The NextDC share price is $14, up 3.1% today and up 2% over 12 months.

This ASX 200 tech share has increased 6% over the past month.

UBS renewed its buy rating on NextDC shares today with a $22.55 target.

This implies potential capital growth of 61% over the next year.

Droneshield Ltd (ASX: DRO)

The Droneshield share price is $1.76, down 1.7% today and down 46% over 12 months.

Over the past month, this ASX 200 industrials share has fallen 2.5%.

Bell Potter renewed its buy rating on Droneshield shares this week.

The broker shaved its 12-month price target from $2.50 to $2.40.

This suggests a potential 35% upside ahead.

WiseTech Global Ltd (ASX: WTC)

The WiseTech share price is $41.89, up 6% today and down 58% over 12 months.

This ASX 200 tech share has risen 21% over the past month.

Morgans reiterated its buy rating on Wisetech shares this week.

The broker cut its target price from $67 to $62.50.

This implies a potential 49% upside ahead.

Qantas Airways Ltd (ASX: QAN)

The Qantas share price is $9.54, down 1.2% today and down 21% over 12 months. 

Over the past month, this ASX 200 airline share has fallen 8%.

Morgan Stanley retained its buy call on Qantas shares today.

The broker raised its target from $12.50 to $12.80.

This suggests a potential 33% upside ahead.

The post 9 ASX 200 shares with strengthened buy ratings this week appeared first on The Motley Fool Australia.

More reading

• Why I think Xero and WiseTech shares are strong buys
• These are the 10 most shorted ASX shares
• 4 ASX shares I'd buy with $5,000 in September
• 3 ASX growth shares to buy in September
• Warren Buffett's playbook: 3 cheap ASX shares that could soar up to 60%

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended DroneShield, Jefferies Financial Group, and WiseTech Global. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares are 0.3% higher at 9,062.7 points on the second last day of earnings season.

Brokers have been reviewing ASX 200 company reports and updating their ratings and 12-month price targets accordingly.

Here are three updates from Morgans.

Woolworths Group Ltd (ASX: WOW)

The Woolworths share price is $38.95, down 1.5% today and up 37% over 12 months.

Woolworths released its FY26 earnings this week.

Morgans reiterated its accumulate rating on the ASX 200 consumer staples share.

The broker raised its 12-month price target from $37.30 to $43.50.

This implies potential capital gains of 11% ahead for Woolworths shares.

Morgans said:

WOW's FY26 result was slightly better than expected. Australian Food earnings were in line with our forecast, while Australian B2B and W Living exceeded expectations. NZ Food was softer following a challenging 2H26.

Encouragingly, Australian Food sales momentum has continued into early FY27, supported by the popular Disney Ooshies collectibles campaign. Excluding this benefit, sales growth remained solid, indicating the underlying business continues to perform well.

Our target price increases to $43.50 (from $37.30), reflecting changes to earnings forecasts and a higher valuation multiple.

The multiple expansion reflects continued positive momentum in the core Australian Food segment, our increased confidence that this sales growth can be sustained, and improved execution.

Ramsay Health Care Ltd (ASX: RHC)

The Ramsay Health Care share price is $50.98, up 1.8% today and up 50% over 12 months.

Ramsay Health Care released its FY26 report this week.

Morgans renewed its hold rating on the ASX 200 healthcare share with a $49.39 target.

This suggests the stock is fully valued.

The broker said:

FY26 underlying NPAT increased 23% and was ahead of expectations, with EBIT growth and positive OCF (ex РSant̩). Australia remained the earnings driver, while UK Acute was the standout and Elysium showed a material 2H turnaround.

Pleasingly, Australia delivered EBIT growth of 11.2% and 30bp margin expansion despite a 4% headwind from new funding at Joondalup public, supported by activity, acuity, theatre utilisation, PHI indexation and cost control.

While we view result quality as encouraging (OCF & ROCE up), FY27 guidance is qualitative, with management only targeting EBIT growth and margin expansion (ex РSant̩), leaving the sustainability question open for debate.

PLS Group Ltd (ASX: PLS)

The PLS Group share price is $5.34, up 3.6% today and up 132% over 12 months. 

PLS Group released its FY26 results this week.

Morgans downgraded the ASX 200 lithium share from hold to trim with a $4.60 target.

This suggests a potential 13% downside ahead.

Morgans commented:

PLS delivered an in-line FY26 Underlying EBITDA result and surprised with a maiden 5cps fully franked final dividend (22% FCF payout).

We view PLS as fairly valued at current levels, with its premium to peers already reflecting the company's best-in-class execution, balance sheet and growth optionality.

Depleted lithium inventories leave scope for short-term upside, though we see the medium-term outlook as more volatile given uncertainty around supply and demand drivers.

The post Buy, hold, sell: Ramsay Health Care, PLS Group, Woolworths shares appeared first on The Motley Fool Australia.

More reading

• These are the 10 most shorted ASX shares
• Buy, hold, sell: Rio Tinto, PLS Group, BHP shares
• ASX 200 mining shares outperform in final week of earnings season
• How to build an ASX portfolio you do not need to check every day
• Here are the top 10 ASX 200 shares today

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The August earnings season is now coming to a close, with just one day left on Monday to go.

Hundreds of S&P/ASX 200 Index (ASX: XJO) companies have announced their next dividends this month.

We're helping you keep track of ex-dividend dates with an article every Friday.

Here are the ASX shares going ex-dividend next week.

We've listed the dividend amounts investors will receive and when they'll receive them.

In order to receive a dividend, you must own the ASX share before its ex-dividend date.

ASX shares with ex-dividend dates next week

The post 37 ASX shares going ex-dividend next week appeared first on The Motley Fool Australia.

More reading

• Up 56%! 3 reasons to still buy BHP shares today
• 2 ASX dividend shares with yields above 7%
• Why this ASX gold-copper stock could rocket 90%
• These are the 10 most shorted ASX shares
• Buy, hold, sell: Rio Tinto, PLS Group, BHP shares

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Aussie Broadband and Pinnacle Investment Management Group. The Motley Fool Australia has positions in and has recommended Amcor Plc, Bendigo And Adelaide Bank, NIB Holdings, and Pinnacle Investment Management Group. The Motley Fool Australia has recommended Ansell, Aussie Broadband, BHP Group, Qualitas, Sonic Healthcare, and Universal Store. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares are down 0.9% to 9,049.3 points on Thursday.

Among the 11 market sectors of the ASX 200, healthcare is the only one in the green, up 0.3%.

As earnings season continues, brokers are busy updating their ratings.

Let's check out some new recommendations.

Neuren Pharmaceuticals Ltd (ASX: NEU)

This ASX healthcare share is $20.60 apiece, up 2.2% today and up 8% over 12 months.

Bell Potter reiterated its buy rating on Neuren Pharmaceuticals shares after the company's 1H FY26 report.

Neuren Pharmaceuticals announced a maiden fully-franked interim dividend of 15 cents per share.

The broker kept its 12-month share price target at $25.50. 

This implies potential capital gains of almost 25% ahead.

Analyst Thomas Wakim said:

The dividend provides a moderate yield for shareholders, however capital growth will dominate future shareholder returns and is the reason to own the stock in our view, particularly as the binary Phase 3 readout in PMS draws closer (estimated in ~1H CY28), the result of which will largely determine whether NEU is a one-trick pony or whether they repeat the glory a second time round with NNZ-2591.

Whitehaven Coal Ltd (ASX: WHC)

The Whitehaven Coal share price is $8.10, up 0.4% today and up 19% over 12 months.

Morgans downgraded its recommendation from buy to hold due to recent share price strength.

After reviewing the miner's FY26 results, the broker reduced its 12-month target from $8.50 to $8.05.

This implies the ASX 200 energy share is already fully valued.

Morgans commented:

WHC delivered a mixed result, with EBITDA broadly in line with consensus expectations, although underlying NPAT missed slightly.

A 6c dividend was declared, consistent with consensus.

The effects of poor coal prices in the 1H provided a significant headwind for the full-year result.

FY27 guidance was softer than expected, with production growth appearing limited given the unchanged upper end of group guidance, while both costs and capital expenditure expectations have moved higher.

Endeavour Group Ltd (ASX: EDV)

The Endeavour share price is $3.05, down 0.5% today and down 23% over 12 months.

Morgans maintained a trim call on the ASX 200 consumer staples share after Endeavour's FY26 report.

The broker cut its target price from $3.20 to $2.95, suggesting a 3% downside ahead.

Morgans said:

There were no major surprises in EDV's FY26 result after the company pre-announced its key numbers (sales, underlying EBIT and underlying NPAT) in early August.

However, the outlook for costs was greater than anticipated as EDV increases investment to execute its new strategy.

Management noted that competition remains intense in the Retail segment, particularly in the online channel, while Hotels sales growth softened in early 1H27 across all key categories (food & beverage, gaming and accommodation).

We expect FY27 to be a disruptive year as EDV implements its transformation initiatives.

Liquor demand also remains under pressure from elevated interest rates, ongoing cost-of-living pressures and a subdued consumer environment.

Given these headwinds and the execution risk associated with the transformation program, we believe the balance of risks remains skewed to the downside.

The post Buy, hold, sell: Whitehaven, Endeavour, Neuren Pharmaceuticals shares appeared first on The Motley Fool Australia.

More reading

• 37 ASX shares going ex-dividend next week
• Here are the top 10 ASX 200 shares today
• Neuren Pharmaceuticals reports lower profit but launches first dividend
• Neuren share price in focus after DAYBU wins EU approval for Rett syndrome
• Endeavour Group FY26 profit tumbles despite sales growth

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares are down 0.8% to 9,057.1 points as earnings season continues today.

After reviewing companies' results, brokers have reduced their ratings on numerous ASX shares.

Let's see a sample.

PLS Group Ltd (ASX: PLS)

The PLS Group share price is $5.23, down 1.2% today and up 123% over 12 months. 

Over the past month, this ASX 200 lithium share has ripped 23% higher.

Morgans downgraded PLS shares from hold to trim after the miner's FY26 results.

The broker commented:

PLS delivered an in-line FY26 Underlying EBITDA result and surprised with a maiden 5cps fully franked final dividend (22% FCF payout).

We view PLS as fairly valued at current levels, with its premium to peers already reflecting the company's best-in-class execution, balance sheet and growth optionality.

Depleted lithium inventories leave scope for short-term upside, though we see the medium-term outlook as more volatile given uncertainty around supply and demand drivers.

The broker retained its 12-month price target of $4.60, which implies a 12% downside ahead.

Paladin Energy Ltd (ASX: PDN)

The Paladin Energy share price is $12.31, down 2.1% today and up 64% over 12 months. 

Over the past month, this ASX 200 energy share has jumped 29%.

Morgans downgraded Paladin Energy shares from buy to accumulate due to recent share price strength.

Following the uranium miner's FY26 report, the broker increased its target price to $14.10.

This suggests a potential 15% upside ahead.

Morgans said:

Cash is starting to flow — PDN delivered positive operating cash flow for the first full year since the restart, generating US$38m in FY26 and marking the transition from ramp-up story to steady-state and cash-generating producer.

Guidance beaten across the board — Langer Heinrich Mine (LHM) exceeded FY26 production, sales and cost guidance, providing further evidence that the operation can sustainably deliver and continues to build momentum as it enters more steady state operations.

Lovisa Holdings Ltd (ASX: LOV) 

The Lovisa share price is $27.14, down 1.7% today and down 34% over 12 months. 

Over the past month, this ASX retail share has soared 27%.

Morgans downgraded Lovisa shares, on valuation grounds, from buy to accumulate after the retailer's FY26 report.

The broker reduced its 12-month price target to $31.

This implies a potential 14% upside ahead.

Ora Banda Mining Ltd (ASX: ORA)

The Ora Banda share price is $1.59, down 1.9% today and up 84% over 12 months. 

Over the past month, this ASX 200 gold share has ripped 42% higher.

MA Financial Group downgraded Ora Banda shares to a hold rating after the miner's FY26 report.

The broker raised its 12-month price target from $1.40 to $1.60.

This implies a potential 1% upside ahead.

Sandfire Resources Ltd (ASX: SFR)

The Sandfire Resources share price is $23.47, down 2.8% today and up 85% over 12 months. 

Over the past month, this ASX 200 copper share has leapt 22%.

The Sandfire Resources share price struck a new record of $25 on the back of its FY26 report yesterday.

Morgans downgraded Sandfire Resources shares from accumulate to hold with a $23 target.

This indicates the stock is fully valued now.

The broker commented:

SFR resumed dividends with a 35cps final dividend (+86% vs expectations) and we see scope for this to build further as its cash balance continues to grow with no drawn debt, supported by a favourable base metals price environment.

SFR's asset quality, management quality and balance sheet strength, alongside emerging growth optionality, underpin its case as a core copper exposure for long-term investors, though the stock appears fully valued at current prices.

Scentre Group (ASX: SCG)

The Scentre share price is $3.57, down 1.4% today and down 12% over 12 months. 

Over the past month, this ASX 200 real estate investment trust (REIT) has fallen 8%.

Jarden downgraded Scentre shares to a hold rating after reviewing the property group's 1H FY26 results.

The broker has a $4.05 target, which suggests a potential 13% upside ahead.

Inghams Group Ltd (ASX: ING)

The Inghams share price is $2.05, up 2.3% today and down 26% over 12 months.

Over the past month, this ASX 200 consumer staples share has fallen 9%.

Jarden downgraded Inghams shares to a hold rating after the company's FY26 results.

The broker's target is $2.50, which implies a potential 22% upside ahead.

The post 7 ASX 200 shares downgraded by brokers this week appeared first on The Motley Fool Australia.

More reading

• These are the 10 most shorted ASX shares
• Buy, hold, sell: Rio Tinto, PLS Group, BHP shares
• ASX 200 mining shares outperform in final week of earnings season
• Here are the top 10 ASX 200 shares today
• 9 ASX 200 shares with strengthened buy ratings this week

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Lovisa. The Motley Fool Australia has recommended Lovisa and Ma Financial Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares are down 0.8% to 9,057.4 points as earnings season continues today.

Meanwhile, three experts share their views on three ASX shares.

Let's take a look.

Breville Group Ltd (ASX: BRG)

The Breville share price is $33.02, down 1.4% today and down 0.5% over 12 months. 

After Breville released its FY26 results, Morgans downgraded the retail stock from buy to accumulate "purely on a valuation basis".

Morgans explained: 

BRG delivered A$207m EBIT (+1% yoy) in line with guidance, in what was an exceptionally challenging year as the group navigated a volatile tariff backdrop and ongoing supply chain shocks via geopolitical conflicts.

Revenue growth was slightly below expectations (~2%), as FX headwinds in the 2H (US ~10%; EMEA ~5%) detracted from the topline.

Growth on a constant currency (cc) basis remains solid (+10%), and ongoing premiumisation tailwinds, and coffee (up double digits), have continued into FY27.

We view BRG as having emerged from this transitional year as a better business, with a robust outlook.

New market expansion continues to accelerate (+74% yoy), the NPD pipeline is strong and new initiatives (Best Buy) are driving a material step-change in sell out performance.

We expect FY27 forecasts may prove conservative, with BRG able to return to a sustainable level of growth in FY27.

Temple & Webster Group Ltd (ASX: TPW)

The Temple & Webster share price is $4.71, down 2.3% today and down 81% over 12 months. 

Bell Potter has a hold rating on this ASX consumer discretionary share following the retailer's FY26 results.

Analyst Chami Ratnapala said: 

While the share trades towards 3-year lows, we see multiple risks related to the revenue recovery from current levels over the next few months in this current macroeconomic context, competitive landscape and following TPW's 4Q26 profit optimisation initiatives.

We factor in some downside risk to current company expectations and see the current trading multiple (0.7x in May-26 vs 1.4x in Aug-22, on BPe) as somewhat pricing in the near-term outlook as TPW sees revenue declines similar to our omni-channel retailer coverage.

Car Group Ltd (ASX: CAR)

The Car Group share price is $28.37, down 3% today and down 29% over 12 months. 

Tony Locantro from Alto Capital has a sell rating on the ASX communications share after Car's FY26 report.

On The Bull this week, Locantro said: 

CAR Group operates leading digital automotive markets in Australia and internationally.

It delivered another strong result in fiscal year 2026. Reported revenue of $A1.253 billion was up 6 per cent on the prior corresponding period. Reported net profit after tax of $A314 million was up 14 per cent.

International operations continue to generate attractive long term growth and management expects further revenue growth in fiscal year 2027.

However, the company's strong operating performance is increasingly reflected in its valuation, which requires sustained double digit growth and continuing successful international execution.

In our view, the risk-reward balance in response to valuation supports a lighten recommendation.

The post Buy, hold, sell: Breville, Car Group, Temple & Webster shares appeared first on The Motley Fool Australia.

More reading

• These are the 10 most shorted ASX shares
• 3 ASX growth shares to buy in September
• 4 ASX All Ords shares with 40% to 90% upside post-results: experts
• 3 ASX shares I'd buy for their global growth potential
• These are the 10 most shorted ASX shares

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Temple & Webster Group. The Motley Fool Australia has recommended CAR Group Ltd and Temple & Webster Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Several ASX mining shares, including BHP Group Ltd (ASX: BHP), reached new 52-week highs on Tuesday.

The BHP share price reached a record $68.22, up 1.6% for the day and 56% over 12 months, in earlier trading.

This pushed two ASX mining exchange-traded funds (ETFs) to record highs as well, given their 40% weighting to BHP shares.

They are SPDR S&P/ASX 200 Resources ETF (ASX: OZR) and Betashares Australian Resources Sector ETF (ASX: QRE).

Meanwhile on Tuesday, the S&P/ASX 200 Index (ASX: XJO) is 0.6% higher at 9,153.6 points.

As earnings season continues, let's look at the other ASX mining shares reaching new peaks today.

Sandfire Resources Ltd (ASX: SFR)

The ASX 200's largest pure-play copper mining share rose 2% to a record $22.89 today.

Genesis Minerals Ltd (ASX: GMD)

ASX 200 gold mining share, Genesis Minerals rose 1.75% to a 52-week high of $8.72 per share.

Capricorn Metals Ltd (ASX: CMM)

Fellow gold mining share, Capricorn Metals, spiked 1.6% to a new record of $18.02 today.

Andean Silver Ltd (ASX: ASL)

ASX silver mining share, Andean Silver increased 6.2% to a record $2.90 per share.

Vault Minerals Ltd (ASX: VAU)

Gold and copper mining share, Vault Minerals rose to a 52-week peak of $7.06, up 1.9%, on Tuesday.

Alkane Resources Ltd (ASX: ALK)

Gold and antimony miner Alkane Resources hit a 52-week high of $1.91 per share.

Carnaby Resources Ltd (ASX: CNB)

Copper and gold miner Carnaby Resources rose 4% to a 52-week high of $1.05 per share.

What about the ASX mining ETFs?

QRE and OZR were among the 6 top-performing ASX ETFs of FY26 amid the new mining boom underway in Australia.

The OZR ETF rose 1.1% to an all-time high of $19.38 on Tuesday.

OZR ETF delivered an exceptional total one-year return of 51% in FY26. The trailing distribution yield was 2.4%.

This ASX ETF seeks to mirror the performance of the S&P/ASX 200 Resources Index.

After BHP (40%), its other top holdings are Rio Tinto Ltd (ASX: RIO) (7.7%) and Woodside Energy Group Ltd (ASX: WDS) (7.4%).

The QRE ETF increased 1.9% to a record $11.16 today.

QRE ETF produced a similarly impressive total one-year return of 50% in FY26. The trailing distribution yield was 2.3%.

This ASX ETF seeks to track the Solactive Australia Resources Sector Index.

After BHP, its next top holdings are also Woodside (7.5%) and Rio Tinto shares (7.4%).

Both ETFs invest predominantly in ASX mining shares, along with oil and gas suppliers, and other resources companies like steel makers.

QRE also invests 2.5% in utilities, which is a key difference to OZR, although Origin Energy Ltd (ASX: ORG) is the only stock.

The post 8 ASX mining shares hitting 52-week highs today appeared first on The Motley Fool Australia.

More reading

• Up 56%! 3 reasons to still buy BHP shares today
• Buy, hold, sell: Rio Tinto, PLS Group, BHP shares
• Experts name 2 ASX 200 blue chip shares to buy this week
• By September 2027, BHP shares could turn $10,000 into…
• 5 things to watch on the ASX 200 on Monday

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended BHP Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares are up 0.74% to 9,168.7 points on Tuesday.

All 11 market sectors of the ASX 200 are in the green today.

Healthcare leads the pack, up 1.1%, extending its impressive recent rebound.

ARB Corporation Ltd (ASX: ARB) is the fastest riser of the ASX 200 today, up 18% on its FY26 report.

Meanwhile, Morgans has issued some new notes on three ASX shares.

They include BHP Group Ltd (ASX: BHP) shares, which hit a new all-time high today.

Let's take a look.

Judo Capital Holdings Ltd (ASX: JDO)

The Judo Capital share price is $1.03, up 6.4% today and down 42% over 12 months. 

Judo Capital shares are the fourth fastest riser on the local bourse despite no significant announcements today.

Morgans has a buy rating on this ASX bank share after its FY26 results.

The broker said: 

FY26 PBT landed towards the top end of the revised guidance range and FY27 guidance was reaffirmed offering strong earnings growth.

EPS forecasts moderated 2-6%.

The broker shaved its 12-month price target from $1.47 to $1.42.

This suggests a potential 40% upside ahead.

Healius Ltd (ASX: HLS)

The Healius share price is 43 cents, down 0.7% today and down 49% over 12 months. 

Since the healthcare sector began its long-awaited rebound on 3 June, Healius shares have soared 29%.

Morgans has a hold rating on this ASX 200 healthcare share following its FY26 report.

The broker said: 

FY26 results were mixed, with revenue and underlying EBITDA broadly in line, but underlying EBIT 5% below consensus and at the bottom of guidance, reflecting still-thin Pathology margins.

Encouragingly, Pathology EBIT margin improved materially in 2H, while labour costs fell 2.9% and group cost growth was contained.

Agilex was again a clear positive, with revenue and earnings growth ahead of expectations.

While FY27 EBIT guidance of A$39.7m is broadly in line with expectations, the T27 target for mid-to-high single-digit EBIT margins was extended by c18 months to Dec-28, leaving us cautious on the pace and sustainability of earnings leverage.

The broker increased its price target to 43 cents, implying the stock is fully valued.

BHP Group Ltd (ASX: BHP)

The BHP share price is $67.93, up 1.2% today and up 57% over 12 months. 

BHP shares reached a new record of $68.22 in earlier trading on Tuesday.

Morgans downgraded BHP shares to a sell call after its FY26 report on 18 August.

The broker explained: 

A solid FY26 result, with an upsized final dividend of US 99cps, against a share price that appears to already factor in more upside, we lower our rating to TRIM.

Metal prices were a key driver, but BHP also maintained a solid operating performance on controllable factors against a tough backdrop in FY26.

The broker reduced its 12-month price target from $59.80 to $55.30.

This suggests a potential 18% downside ahead.

The post Buy, hold, sell: Judo Capital, Healius, BHP shares appeared first on The Motley Fool Australia.

More reading

• Up 56%! 3 reasons to still buy BHP shares today
• Buy, hold, sell: Rio Tinto, PLS Group, BHP shares
• Experts name 2 ASX 200 blue chip shares to buy this week
• By September 2027, BHP shares could turn $10,000 into…
• Are these 2 top Vanguard ETFs still worth buying today?

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended ARB Corporation. The Motley Fool Australia has recommended ARB Corporation and BHP Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The BHP Group Ltd (ASX: BHP) share price reached a new all-time record of $68.22, up 1.6%, on Tuesday.

Meanwhile, the S&P/ASX 200 Index (ASX: XJO) is 0.8% higher as earnings season continues.

BHP shares have now exceeded all the new 12-month price targets set by experts since its FY26 report on 18 August.

There is no news from the ASX 200's most valuable company by market capitalisation today.

What's pushing the BHP share price higher?

It's certainly an interesting situation given there is just one buy rating among 11 experts since the miner released its results.

That buy call came from Morgan Stanley.

The top broker retained its buy call on the ASX 200 mining giant and raised its 12-month target from $67 to $67.50 post-results.

That was the highest target price among the 11 experts.

Nine experts reiterated their hold calls on BHP shares after the FY26 report.

However, Morgans downgraded the ASX 200 mining share to a sell with a $55.30 target, implying a 19% downside ahead.

The lowest 12-month target among the 11 brokers is $51.43 from Deutsche Bank.

This suggests a potential 24% downside over the next 12 months.

What did BHP report for FY26?

BHP reported a record underlying earnings before interest, taxes, depreciation, and amortisation (EBITDA) of US$32.9 billion for FY26.

That was 27% higher than FY25.

A 6% unit cost reduction across major assets and increased production at its coal and iron ore mines contributed to a 30% profit boost.

Underlying attributable profit came in at US$13.2 billion, up 30%, and net operating cash flow was US$21.8 billion, up 17%.

While BHP has a long history as an iron ore giant, in recent years, it has become the world's largest copper producer.

The red metal accounted for 54% of BHP's EBITDA in FY26.

What else is going on?

The miner is benefiting from a lift in the iron ore and copper prices today.

The copper price is up 0.3% to US$6.61 per pound on Tuesday.

Copper hit a new all-time price peak of US$6.71 per pound on 5 August amid higher demand due to the green energy transition.

The copper price is up 16% in the 2026 calendar year so far and up 48% over 12 months.

The iron ore price is up 0.14% to US$95.34 per tonne today.

Iron ore slipped below US$100 per tonne just after the start of the new financial year.

This followed about three years of trading mostly above it.

Trading Economics analysts explained the recent weakness:

China's steel output fell 3.6% year-on-year to 76.93 million tons in July, the lowest for the month since 2017, while inventories remained elevated.

Weak property activity weighed on demand, with home prices down 3.2% year-on-year, while only about one-third of steelmakers were profitable.

China's July iron ore imports also fell 4% month-on-month to 108.09 million tons as shrinking steel margins prompted some mills to undertake maintenance.

However, fresh stimulus measures and expectations of higher demand ahead of the September peak season are supporting the iron ore price today.

China is planning measures to boost domestic demand and growth.

The National Development and Reform Commission (NDRC) is also urging local governments to accelerate major projects.

Chinese steel production is a key driver of global iron ore demand.

The post BHP share price hits new record high appeared first on The Motley Fool Australia.

More reading

• Up 56%! 3 reasons to still buy BHP shares today
• Buy, hold, sell: Rio Tinto, PLS Group, BHP shares
• Experts name 2 ASX 200 blue chip shares to buy this week
• By September 2027, BHP shares could turn $10,000 into…
• Are these 2 top Vanguard ETFs still worth buying today?

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended BHP Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares are up 0.4% to 9,142.1 points on Tuesday.

As earnings season continues, let's check out some new ratings from the experts today.

DigiCo Infrastructure REIT (ASX: DGT)

The DigiCo Infrastructure REIT share price is $2.47, down 0.4% today and down 22% over 12 months. 

Morgans has a buy rating on this ASX 300 real estate investment trust (REIT) after reviewing its FY26 report.

The broker said: 

The signed Letters of Intent (LOIs) over the remaining 52MW would take the Australian portfolio to full capacity — a strong demand signal that de-risks management's pathway to $250m of EBITDA.

However the ramp-up in earnings is back-ended, hence FY27 guidance was ~8% below MorgansF and ~13% below Consensus.

Liquidity of ~$1.2bn funds the ~$1.2bn capex bill, with management calling out no need for additional equity.

We still see clear value, but the cashflows are pushed out — this is now an FY28-into-FY29 story.

Telstra Group Ltd (ASX: TLS)

The Telstra share price is steady at $4.72 on Tuesday, and down 6% over 12 months. 

John Athanasiou from Red Leaf has a hold call on this ASX 200 communications share following the telco's FY26 results.

He explained (courtesy The Bull):

Telstra's investment case has improved materially, supported by a stronger mobile business, better earnings momentum and improving shareholder returns.

Its mobile network remains the company's key competitive advantage, providing pricing power, scale and dependable cash generation.

The market has increasingly recognised Telstra's defensive qualities, which, we believe, are reflected in the share price.

Telecommunications also remains a capital intensive industry, requiring significant ongoing investment to maintain network leadership.

For existing shareholders, the combination of relatively stable earnings, dividends and a strong mobile franchise remains attractive.

However, for new investors, the upside appears less compelling after a recent re-rating.

Telstra is among 16 ASX 200 shares going ex-dividend this week.

The telco will pay a 90% franked dividend of 10.5 cents per share on 24 September.

Commonwealth Bank of Australia (ASX: CBA)

The CBA share price is $158.83, up 1.3% today and down 7% over 12 months. 

Tony Locantro from Alto Capital has a sell rating on the market's biggest ASX 200 bank share following its FY26 results.

Locantro said: 

The CBA remains Australia's leading banking franchise and delivered another strong result in full year 2026.

Cash net profit after tax of $10.982 billion was up 7 per cent on the prior corresponding period. The full year dividend of $5.05 a share, fully franked, was up 4 per cent.

Strong lending, deposit growth and a robust capital position continue to demonstrate the quality of the business.

However, operating expenses and loan impairment expenses increased.

The CBA continues to trade at a substantial valuation premium to domestic banking peers. Although the underlying business remains strong, the premium valuation leaves little room for disappointment and may potentially constrain prospective returns.

The post Buy, hold, sell: DigiCo Infrastructure REIT, CBA, Telstra shares appeared first on The Motley Fool Australia.

More reading

• Why Liontown, Northern Star and Telstra shares are turning heads on Monday
• Are these 2 top Vanguard ETFs still worth buying today?
• Buy, hold, sell: Commonwealth Bank, Goodman Group, CSL shares
• The 2 top yielding ASX 200 bank stocks revealed (Hint: Not CBA shares)
• Are ASX bank shares a buy in September?

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Telstra Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares are up 0.27% to 9,086.2 points as earnings season continues on Monday.

Among the 11 market sectors, materials and miners are in the lead today, up 1.7%.

The sector pushed higher amid BHP Group Ltd (ASX: BHP) shares reaching a new record of $67.72, up 3.9%, in early trading.

The financials sector is the laggard today, down 1%.

Let's check out some new expert ratings on three ASX 200 sector heavyweights.

Pro Medicus Ltd (ASX: PME)

The Pro Medicus share price is $191.56, down 0.02% today and down 37% over 12 months. 

Pro Medicus shares jumped 7.1% last week after the company released its FY26 results.

The Pro Medicus share price is up 20% since the downtrodden healthcare sector pivoted on 3 June. 

Morgans maintained its accumulate rating on Pro Medicus shares after the report.

Analyst Iain Wilkie said: 

FY26 confirms PME is executing at an even higher level than the market gave it credit for. EBIT margin of 74.9% and constant currency EBIT growth of 30.6% both beat expectations comfortably, with the FX-driven softness in headline revenue a currency story, not a demand or execution one.

Momentum remains broad-based, implementations are ahead of schedule, renewals are a clean sweep, and the pipeline is opening up in new segments rather than just deepening in existing ones.

Looking ahead, FY27 is shaping as a genuine standout year. With four Trinity cohorts and 15 other implementations already banked rather than still ramping, the P&L gets the full run-rate benefit without needing fresh signings just to stand still.

Nothing in the result gives us any pause for change versus our positive view.

Fortescue Ltd (ASX: FMG)

The Fortescue share price is $18.08, up 1.8% today and down 10% over 12 months. 

Morgans has a hold rating on this ASX 200 mining share following the company's FY26 report last week.

Analyst Adrian Prendergast said: 

A mixed FY26 result from FMG, with higher revenue helping to offset cost increases and elevated admin/R&D to help keep underlying earnings flat.

With the focus on FY27 guidance, Iron Bridge remained a key issue, with the magnetite operation struggling through ramp up and with elevated costs.

Plans for a green steel plant was big news, although difficult to quantify.

Commonwealth Bank of Australia (ASX: CBA)

The CBA share price is $155.24, down 1.7% today and down 9% over 12 months. 

CBA reported a 7% increase in its cash net profit after tax (NPAT) to $11 billion for FY26.

John Athanasiou from Red Leaf Securities has a sell rating on this ASX 200 bank share. 

He explained (courtesy The Bull):

CBA shares deserves to trade at a premium given its dominant retail franchise, strong technology platform, solid deposit base and consistent execution.

However, Australian banking remains a mature industry, with intense competition across mortgages and deposits limiting the potential for outsized earnings growth.

At a premium valuation, investors are paying a higher price for quality, leaving little room for disappointment.

After a substantial re-rating, investors may be better served taking some profits and reallocating capital towards businesses offering stronger growth at more reasonable valuations.

The post Buy, hold, sell: Pro Medicus, Fortescue, CBA shares appeared first on The Motley Fool Australia.

More reading

• How much could the Pro Medicus share price rise in the next year?
• Are these 2 top Vanguard ETFs still worth buying today?
• Buy, hold, sell: Commonwealth Bank, Goodman Group, CSL shares
• The 2 top yielding ASX 200 bank stocks revealed (Hint: Not CBA shares)
• Are ASX bank shares a buy in September?

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended BHP Group and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares are 0.3% higher at 9,086.1 points on Monday.

Let's start the new week with some fresh ratings from the experts

CSL Ltd (ASX: CSL)

The CSL share price is $170.37, up 1.3% today and down 21% over 12 months. 

CSL shares soared 23% last week after the company released its FY26 results and provided a positive outlook.

The CSL share price has ripped 85% since the healthcare sector began its long-awaited rebound on 3 June.

Morgans has a buy rating on this ASX 200 healthcare giant.

Analyst Derek Jellinek said: 

The FY26 result was broadly in line with expectations, with revenue of US$15.8bn (+3% vs guidance) and underlying NPATA of US$3.1bn.

Importantly, underlying Ig demand remains strong, Seqirus delivered seasonal influenza growth despite lower US immunisation rates and transformation savings reached US$176m ahead of target, although Vifor continues to face challenges.

While FY27 targets flat top line growth, as Vifor remains a significant drag, the earnings trajectory is becoming increasingly skewed towards recovery, supported by stabilising plasma economics, cost-outs and improved commercial execution.

We make modest changes to FY27-28 estimates and increase our blended DCF, PE and EV/EBITDA-based target price to A$187.71 on a multiple roll forward.

BHP Group Ltd (ASX: BHP)

The BHP share price hit a new record high of $67.72, up 3.9%, in early trading on Monday.

BHP released its FY26 report last week, and following this, John Athanasiou from Red Leaf Securities gave the miner a hold rating.

Athanasiou said (courtesy The Bull):

The company posted attributable profit of $US9.8 billion in full year 2026, up 9 per cent on the prior corresponding period. Revenue of $US58.8 billion was up 15 per cent.

The company's copper portfolio is positioned to benefit from electrification, renewable infrastructure, power grid investment and data centre growth.

However, BHP remains heavily exposed to iron ore, leaving earnings sensitive to Chinese demand and commodity price movements.

The quality of BHP's asset base, balance sheet and diversified portfolio leaves existing shareholders with little reason to sell.

However, after a solid run, prospective investors may be better served waiting for a potentially more attractive entry point.

Westpac Banking Corp (ASX: WBC)

The Westpac share price is $33.60, down 0.7% today and down 12% over 12 months. 

Following Westpac's 3Q FY26 update, Athanasiou put a sell rating on the ASX 200 bank share. 

He said: 

The bank remains well capitalised and continues to generate solid earnings, but the operating environment is becoming increasingly competitive.

Mortgage pricing is aggressive, deposit competition remains intense and the scope for sustained margin expansion appears limited.

Westpac's dividend remains attractive, but investors should also consider opportunity cost.

We believe there are more compelling opportunities on the ASX, which offer stronger structural growth or more attractive valuations.

The post Buy, hold, sell: CSL, BHP, Westpac shares appeared first on The Motley Fool Australia.

More reading

• Up 56%! 3 reasons to still buy BHP shares today
• Buy, hold, sell: Rio Tinto, PLS Group, BHP shares
• Experts name 2 ASX 200 blue chip shares to buy this week
• By September 2027, BHP shares could turn $10,000 into…
• Are these 2 top Vanguard ETFs still worth buying today?

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended BHP Group and CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

ASX 200 healthcare shares vastly outperformed their peers, rising 9.21%, as earnings season continued last week.

Pleasing FY26 reports from heavyweights CSL Ltd (ASX: CSL) and Pro Medicus Ltd (ASX: PME) turbocharged the sector.

The broader S&P/ASX 200 Index (ASX: XJO) slipped 0.62% over the week to 9,058.9 points on Friday.

Healthcare is in the middle of a rapid recovery following a 29% slump over the 12 months to early June.

The S&P/ASX 200 Health Care Index (ASX: XHJ) reached a 9-year low on 3 June.

The sector then pivoted as value investors rushed in to snap up blue-chips on the cheap.

Healthcare shares have skyrocketed 41% since 3 June, compared to a 3% rise for the ASX 200.

Let's review some specifics from last week.

Healthcare shares led the ASX sectors last week

Last week, several major healthcare companies revealed their latest periodic earnings results.

The CSL share price leapt 23.3% to $168.30 on the strength of its FY26 results last week.

CSL shares have rocketed 82% since the healthcare sector rebound began on 3 June.  

Pro Medicus shares jumped 7.1% to $191.60 on the back of the company's FY26 report.

The Pro Medicus share price is up 20% since 3 June. 

The Cochlear Ltd (ASX: COH) share price rose 1.4% to $135.48 following the hearing implant maker's FY26 report.

Cochlear shares have increased 42% since 3 June.

The Healius Ltd (ASX: HLS) share price jumped 13.8% to 46 cents following its FY26 report last week.

Healius shares are up 38% since 3 June.

The EBOS Group Ltd (ASX: EBO) share price ascended 7.2% to $18.96 following the company's FY26 results.

EBOS shares are up 20% since 3 June.

The Mesoblast Ltd (ASX: MSB) share price lifted 6.8% to $2.36 following a phase 3 trial update.

Mesoblast shares have risen 17% since 3 June.  

ASX 200 market sector snapshot

Here's how the 11 market sectors stacked up last week, according to CommSec data.

Over the five trading days:

The post ASX 200 healthcare shares soar 9% amid notable FY26 reports from CSL, Pro Medicus appeared first on The Motley Fool Australia.

More reading

• Experts name 2 ASX 200 blue chip shares to buy this week
• 5 things to watch on the ASX 200 on Monday
• How much could the Pro Medicus share price rise in the next year?
• 5 superannuation mistakes that could shrink your nest egg
• Buy, hold, sell: Commonwealth Bank, Goodman Group, CSL shares

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Cochlear. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended CSL, Cochlear, and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares are down 0.4% to 9,052.4 points on Friday.

Amid earnings season, brokers continue to reassess their ratings and 12-month targets on ASX 200 shares post-results.

Let's check out some new notes from Morgans and Bell Potter.

Sonic Healthcare Ltd (ASX: SHL)

The Sonic Healthcare share price is $20.93, down 2.1% today and down 16% over 12 months. 

Bell Potter maintained its buy call on this ASX 200 healthcare share after reviewing the company's FY26 report.

The broker shaved its 12-month share price target down from $28.75 to $27.50.

This implies a possible 31% upside ahead.

Bell Potter commented:

SHL reported EBITDA of c.$1.92b (cc) which was within the guidance range of c.$1.87b – c.$1.95b.

On a reported basis, EBITDA of c.$1.93 was in line with consensus, but c.1.5% below BPe.

The result was impacted by a range of nonrecurring items that more than offset the one-off gain from the Brisbane lab sale &
leaseback transaction.

While the headline EBITDA margin was c.10bp lower than pcp, margins in the 2H showed meaningful improvement at c.19% v
c.16.7%.

Sonic Healthcare is benefitting from a broader sector rebound since 3 June.

The S&P/ASX 200 Health Care Index (ASX: XHJ) has risen 41% since then, compared with a 3% bump for the ASX 200.

The Sonic Healthcare share price has improved 11% since 3 June.

Super Retail Group Ltd (ASX: SUL)

The Super Retail share price is $13.43, down 7.1% today and down 28% over 12 months. 

Morgans maintained its hold rating on the ASX 200 consumer discretionary share after reading the FY26 report.

The broker increased its 12-month share price target from $12.30 to $15.20.

This suggests a potential 13% upside ahead.

Morgans said: 

SUL delivered a better-than-expected FY26 result, as rebel World Cup tailwinds (+70% volume growth vs last WC), a resilient SCA through June and a lower tax rate (~26%) beat consensus normalised NPAT expectations by ~11%.

Gross margins remained stable at the group level (+10bps yoy) and trading through FY27 is mixed (SCA leading; BCF/rebel muted; and Macpac underperforming), with group LFL growth of +1.5% through the first seven weeks.

A positive update, driven by outperformance from SUL's core SCA/rebel brands, while BCF is continuing to progress on strategic initiatives (store format/fitment), delivering +5.5% total sales growth and cycling easing comps in the near-term.

Despite a solid start to FY27, we view the valuation (~14x PE) as reasonable relative to near-term growth expectations.

APA Group (ASX: APA)

The APA share price is $10.55, up 3.5% today and up 19% over 12 months. 

Morgans kept its trim rating on this ASX 200 utilities share in place after reviewing the FY26 results.

The broker has a 12-month share price target of $8.66.

This implies a potential 16% downside ahead.

Morgans explained its sell rating on APA shares: 

Operating earnings growth driven by inflation, new assets and cost-out.

Long-term capital management means earnings growth does not convert into DPS growth.

Forecast EBITDA upgrades from cost-outperformance.

APA has an attractive cash yield of 5.9% at current prices on FY27 DPS guidance, but share price downside risk is material.

The post Buy, hold, sell: Super Retail, APA, Sonic Healthcare shares appeared first on The Motley Fool Australia.

More reading

• 3 ASX dividend shares raising dividends like clockwork
• How to build an ASX portfolio you do not need to check every day
• Why I think these boring ASX shares could build serious wealth
• How much passive income can I earn off a $1 million superannuation balance?
• 37 ASX shares going ex-dividend next week

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Super Retail Group. The Motley Fool Australia has positions in and has recommended Apa Group and Super Retail Group. The Motley Fool Australia has recommended Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.